BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29737462)

  • 1. Validation of PLASMIC score and follow-up data in a cohort of patients with suspected microangiopathies from Southern Italy.
    Tiscia GL; Ostuni A; Cascavilla N; Cappucci F; Scalzulli P; Battista C; Abrescia A; Aucella F; Buquicchio C; Brigante M; D'Andrea G; Di Paolo B; Giordano G; Infante B; Piano S; Ranieri P; Tullo L; Grandone E
    J Thromb Thrombolysis; 2018 Aug; 46(2):174-179. PubMed ID: 29737462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.
    Bendapudi PK; Hurwitz S; Fry A; Marques MB; Waldo SW; Li A; Sun L; Upadhyay V; Hamdan A; Brunner AM; Gansner JM; Viswanathan S; Kaufman RM; Uhl L; Stowell CP; Dzik WH; Makar RS
    Lancet Haematol; 2017 Apr; 4(4):e157-e164. PubMed ID: 28259520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre.
    Tufano A; Polimeno M; Matani B; Cardillo G; Capasso F; Mormile R; Paladino F; Di Minno G
    Blood Transfus; 2023 Jul; 21(4):345-349. PubMed ID: 35969133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis.
    Kim CH; Simmons SC; Williams LA; Staley EM; Zheng XL; Pham HP
    Transfusion; 2017 Nov; 57(11):2609-2618. PubMed ID: 28646526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.
    Li A; Khalighi PR; Wu Q; Garcia DA
    J Thromb Haemost; 2018 Jan; 16(1):164-169. PubMed ID: 29064619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the PLASMIC score for predicting ADAMTS13 activity <10% in patients with suspected thrombotic thrombocytopenic purpura in Alberta, Canada.
    Wynick C; Britto J; Sawler D; Parker A; Karkhaneh M; Goodyear MD; Sun HL
    Thromb Res; 2020 Dec; 196():335-339. PubMed ID: 32977133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea.
    Park SH; Kim HK; Jeong J; Lee SH; Lee YJ; Kim YJ; Jo JC; Lim JH
    Ann Lab Med; 2023 Sep; 43(5):485-492. PubMed ID: 37080750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified PLASMIC score including the lactate dehydrogenase/the upper limit of normal ratio more accurately identifies Chinese thrombotic thrombocytopenic purpura patients than the original PLASMIC score.
    Zhao N; Zhou L; Hu X; Sun G; Chen C; Fan X; Zhou S; Tao X; Liu H; Zheng C
    J Clin Apher; 2020 Apr; 35(2):79-85. PubMed ID: 31724781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validation and modification of PLASMIC score by adjusting the criteria of mean corpuscular volume and international normalized ratio.
    Lee JA; Lin MH; Kang CM; Chuang MK; Fung CKB; Lo SC
    J Clin Apher; 2023 Oct; 38(5):582-589. PubMed ID: 37325919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the PLASMIC score, a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis, in Chinese patients.
    Tang N; Wang X; Li D; Sun Z
    Thromb Res; 2018 Dec; 172():9-13. PubMed ID: 30340093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals.
    Liu A; Dhaliwal N; Upreti H; Kasmani J; Dane K; Moliterno A; Braunstein E; Brodsky R; Chaturvedi S
    Transfusion; 2021 Jan; 61(1):266-273. PubMed ID: 33179792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of absolute immature platelet count to the PLASMIC score at presentation in predicting ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura.
    Reeves HM; Maitta RW
    Thromb Res; 2022 Jul; 215():30-36. PubMed ID: 35617796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the PLASMIC score at a University Medical Center.
    Jajosky R; Floyd M; Thompson T; Shikle J
    Transfus Apher Sci; 2017 Aug; 56(4):591-594. PubMed ID: 28764998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of PLASMIC Score in Risk Prediction of Thrombotic Thrombocytopenic Purpura: Real-World Experience From a Tertiary Medical Center in Taiwan.
    Lee CH; Huang YC; Li SS; Hsu YT; Chen YP; Chen TY
    Front Med (Lausanne); 2022; 9():893273. PubMed ID: 35615090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
    Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
    Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores.
    Baysal M; Hindilerden F; Ümit EG; Demir AM; Keklik Karadağ F; Saydam G; Akpınar S; Turgut B; Özkocaman V; Özkalemkaş F; Çiftçiler R; Özlü C; Demircioğlu S; İpek Y; Diz Küçükkaya R
    Turk J Haematol; 2023 Dec; 40(4):251-257. PubMed ID: 37791641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of PLASMIC score: an academic medical center case series (2012-present).
    Moosavi H; Ma Y; Miller MJ; Duncan A
    Transfusion; 2020 Jul; 60(7):1536-1543. PubMed ID: 32588918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.
    Mancini I; Agosti P; Boscarino M; Ferrari B; Artoni A; Palla R; Spreafico M; Crovetti G; Volpato E; Rossini S; Novelli C; Gattillo S; Barcella L; Salmoiraghi M; Falanga A; Peyvandi F;
    Orphanet J Rare Dis; 2022 Jun; 17(1):246. PubMed ID: 35739601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.